Pierre Armand Morgon

Pierre Armand Morgon

Chairman bij EUROCINE VACCINES AB

Vermogen: 25 004 $ op 31-03-2024

61 jaar
Health Technology
Consumer Services
Finance

Profiel

Pierre Armand Morgon is currently the CEO of Mrgn Advisors and Drug Abuse Sciences.
He is also the Chief Executive Officer & Manager of MRGN Advisors SARL.
Additionally, he holds the position of Chairman at Eurocine Vaccines AB, Kupando GmbH, MYCB1 Group BV, MYCB1 BV, Health Technology Holding Srl, and Amoéba SA. He serves as a Non-Executive Director at Univercells SA and Limula Biotech.
Furthermore, he is an Independent Non-Executive Director at Barinthus Biotherapeutics Plc and an Advisor at CUBE Labs Srl.
In the past, Dr. Morgon has worked as the Chief Executive Officer of AJ Biologics Sdn.
Bhd.
and as the Chairman of Virometix AG and Alma Biotherapeutics.
He has also held positions as a Marketing Director at Cegedim SA, an Independent Director at Theradiag SA, and an Independent Non-Executive Director at CanSino Biologics, Inc. He served as a Director at Schering-Plough SAS and as a Non-Executive Director at Vaccitech (UK) Ltd.
Additionally, he was the Chief Operating Officer at Valerio Therapeutics SA and the VP-Franchise & Global Marketing Strategy at Sanofi Pasteur.
Dr. Morgon's education includes an undergraduate degree from INSEAD and the International Institute for Management Development, an MBA from ESSEC Business School, a doctorate from the University of Lyon, and a graduate degree from Jean Moulin University Law School.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
13-03-2024 10 506 ( 0.03% ) 25 004 $ 31-03-2024

Actieve functies van Pierre Armand Morgon

BedrijvenFunctieBegin
EUROCINE VACCINES AB Chairman 01-06-2019
AMOÉBA Director/Board Member 17-12-2020
BARINTHUS BIOTHERAPEUTICS PLC Director/Board Member 01-01-2018
Drug Abuse Sciences Chief Executive Officer 01-01-2006
Director/Board Member -
Consultant / Advisor -
Chairman 01-12-2021
MYCB1 BV Chairman 01-07-2020
MRGN Advisors SARL Chief Executive Officer -
░░░░░░░ ░░ ░░░░░░░░ -
░░░░░ ░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
Alle actieve functies van Pierre Armand Morgon

Eerdere bekende functies van Pierre Armand Morgon

BedrijvenFunctieEinde
░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░ ░░░░░░░░░ ░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░ ░ ░░░░░░░░░ ░░░░░░░░░░
Ervaring van Pierre Armand Morgon in detail bekijken

Opleiding van Pierre Armand Morgon

INSEAD Undergraduate Degree
International Institute for Management Development Undergraduate Degree
ESSEC Business School Masters Business Admin
University of Lyon Doctorate Degree
Jean Moulin University Law School Graduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Pierre Armand Morgon in detail bekijken

Connecties

88

Eerstegraads connecties

29

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven6
EUROCINE VACCINES AB

Health Technology

CEGEDIM

Technology Services

VALERIO THERAPEUTICS

Health Technology

AMOÉBA

Consumer Non-Durables

CANSINO BIOLOGICS INC.

Health Technology

BARINTHUS BIOTHERAPEUTICS PLC

Health Technology

Bedrijven in privébezit18

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Alma Biotherapeutics

Mrgn Advisors

Drug Abuse Sciences

Finance

Health Technology

Commercial Services

Health Technology

MYCB1 Group BV

MRGN Advisors SARL

MYCB1 BV

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Pierre Armand Morgon